Traumatic brain injury (TBI) is a significant clinical problem with few therapeutic interventions
successfully translated to the clinic. Increased importance on the progressive, long-term …

The launch of the US BRAIN and European Human Brain Projects coincides with growing
international efforts toward transparency and increased access to publicly funded research …

Intravenous (IV) infusion of bone marrow‐derived mesenchymal stem/stromal cells (MSCs)
stabilizes the blood‐spinal cord barrier (BSCB) and improves functional recovery in …

Scientists who perform major survival surgery on laboratory animals face a dual welfare and
methodological challenge: how to choose surgical anesthetics and post-operative …

Intravenous infusion of mesenchymal stem cells (MSCs) derived from adult bone marrow
improves behavioral function in rat models of spinal cord injury (SCI). However, most studies …

Cytokines are involved in neural homeostasis and pathological processes associated with
neuroinflammation after spinal cord injury (SCI). The biological effect of cytokines, including …

Intravenous infusion of mesenchymal stem cells (MSCs) has been shown to reduce the
severity of experimental spinal cord injury (SCI), but mechanisms are not fully understood …

A variety of neurotrophic factors have been used in attempts to improve morphological and
behavioural outcomes after experimental spinal cord injury (SCI). Here we review many of …

Traumatic brain injury (TBI) is a major public health issue exacting a substantial personal
and economic burden globally. With the advent of “big data” approaches to understanding …

Resveratrol, a polyphenol found in various plants, including grapes, plums and peanuts has
shown various medIRInal properties, including antioxidant, protection of cardiovascular …